서울 지역을 대상으로 모집된 유.소아기 아토피피부염 환아의 삶의 질과 경제적 비용 부담에 관한 조사 = The Burden of Atopic Dermatitis on Children and Their Families : Quality of Life and Financial Impact in Seoul Area

다국어 초록 (Multilingual Abstract)

Objective : Atopic dermatitis (AD) in children may profoundly affect the quality of life (QOL), and also cause financial burden, to the families of those suffering from this ailment. The aim of our study was to examine the quality of life and the financial burden of atopic dermatitis in children and their families to evaluate this relationship with the degree of AD. Methods : 37 infant and child atopic dermatitis patients were included and evaluated using the SCORing of Atopic Dermatitis (SCORAD) Index and Eczema Area and Severity Index (EASI). Patients and carers were asked to fill in the questionnaires about their quality of life and financial costs during the past year. Data about sleep disturbance and pruritus were also obtained. Pearson's correlation was used for statistical analysis. Results : 1. The mean score of Children's Dermatology Life Quality Index (CDLQI) was $10.52{\pm}4.82$, Infants' Dermatologic Quality of Life (IDQOL) was $8.21{\pm}3.95$. 2. The mean score of Family Dermatology Life Quality Index (FDLQI) was $13.30{\pm}5.72$, Dermatitis Family Impact (DFI) was $12.5{\pm}4.98$. 3. By analyzing the questionnaire, the monthly average cost was determined to be 730,800 won for each patient : the direct cost was 283,500 won, and the indirect cost was 447,300 won. 4. By analyzing the correlation between the severity of AD and QOL, subjective SCORAD were significantly and positively correlated with QOL(IDQOL, FDLQI, DFI, CDLQI). 5. By analyzing the correlation between the severity of AD and any economic impact, EASI were significantly and positively correlated with the direct cost. Conclusion : The above results show that the QOL of the patients and carers is significantly related to their disease severity. Atopic dermatitis patients pay an average of 730,800 won a month, and the economic impact on the patients is significantly related to their disease severity. The CDLQI, IDQOL, FDLQI and DFImay potentially be of value to help in the appropriate management of AD and can be used as an added measurement in clinical trials involving AD management.

참고문헌 (Reference)

1 박창근, "유？소아기 아토피피부염이 환아의 삶의 질과 가족에 미치는 영향" 대한피부과학회 45 (45): 429-438, 2007

2 김은정, "아토피피부염 환자의 삶의 질과 경제적 부담에 관한 연구" 대한피부과학회 46 (46): 160-170, 2008

3 진현우, "아토피피부염 환자의 대체의학 이용 실태에 관한 연구" 대한피부과학회 43 (43): 903-911, 2005

4 유일영, "아토피 피부염 환아 어머니의 양육 스트레스와 간호 요구" 아동간호학회 10 (10): 423-430, 2004

5 김성현, "소아청소년 아토피피부염 환자의 애착반응 및 부모의 삶의 질과의 관계" 대한피부과학회 46 (46): 1457-1462, 2008

6 신나라, "소아기 아토피피부염이 가족에 미치는 영향에 관한 연구" 38 (38): 94-499, 2000

7 이희정, "성인 아토피피부염 환자에서 삶의 질 평가의 임상적 유용성" 대한피부과학회 45 (45): 159-164, 2007

8 윤영희, "서울 지역을 대상으로 모집된 성인 아토피피부염 환자의 삶의 질과 경제적 비용 부담에 관한 조사" 대한한방안이비인후피부과학회 23 (23): 199-214, 2010

9 Hanifin JM, "the EASI Evaluator Group. The eczema area and severity index(EASI). assessment of reliability in atopic deermatitis" 10 : 11-18, 2001

10 Emerson RM, "What is the cost of atopic dermatitis in preschool children?" 144 : 514-522, 2001

11 Mancini AJ, "The socioeconomic impact of atopic dermatitis in the United States: a systematic review" 25 (25): 1-6, 2008

12 Lawson V, "The family impact of childhood atopic dermatitis: the Dermatitis Family Impact Questionnaire" 138 : 107-113, 1998

13 Fivenson D, "The effect of atopic dermatitis on total burden of illness and quality of life on adults and children in a large managed care organization" 8 (8): 333-342, 2002

14 Verboom P, "The cost of atopic dermatitis in the Netherlands : an international comparison" 147 : 716-724, 2002

15 Lewis-Jones MS, "The Infinats' Dermatitis Quality of Life Index" 144 : 104-110, 2001

16 Basra MK, "The Family Dermatology Life Quality Index: measuring the secondary impact of skin disease" 156 (156): 528-538, 2007

17 Basra MK, "The Family Dermatology Life Quality Index: measuring the secondary impact of skin disease" 156 (156): 528-538, 2007

18 Lewis-Jones MS, "The Children's Dermatology Life Quality Index (CDLQI): initial validation and practical use" 132 (132): 942-949, 1995

19 Christie L, "The Burden of Atopic Dermatitis: Impact on the Patient, Family, and Society" 2 (2): 192-199, 2005

20 Ben-Gashir MA, "Quality of life and disease severity are corrleated in children with atopic dermatitis" 150 : 284-290, 2004

21 Leung DY, "New insights into atopic dermatitis" 133 : 651-657, 2004

22 Nicole Jenner, "Morbidity and cost of atopic eczema" 45 : 16-22, 2004

23 S. Howlett, "Emotional dysfunction, child. family relationships and childhood atopic dermatitis" 140 : 381-384, 1991

24 Balkrishnan R, "Disease severity and associated family impact in childhood atopic dermatitis" 88 : 423-427, 2003

25 Hanifin JM, "Diagnostic features of atopic dermatitis" 92 : 44-47, 1980

26 Ehlken B, "Cost-of-illness study in patients suffering from atopic eczema in Germany" 56 (56): 1144-1151, 2005

27 Ellis CN, "Cost of atopic dermatitis and eczema in the United States" 46 : 361-370, 2002

28 Martin Barbeau M, "Bpharm. Burden of Atopic dermatitis in Canada" 45 (45): 31-36, 2006

29 Su JC, "Atopic eczema:its impact on the family and financial cost" 76 : 159-162, 1997

30 Ricci G, "Atopic dermatitis: quality of life of young Italian children and their families and correlation with severity score" 18 (18): 245-249, 2007

31 Lapidus CS, "Atopic dermatitis inchildren: who cares? Who pays?" 28 (28): 699-703, 1993

32 Ricci G, "Atopic Dermatitis in Italian Children: Evaluation of Its Economic Impact" 20 (20): 311-315, 2006

33 Hong SJ, "Association of Allergy and Respiratory Diseases: Report of Korean ISAAC epidemiologic study for asthma and allergic diseases in children" 17 (17): 55-66, 2007